Report full results from the CATALYST trial
Delivered after the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 1 Nov 2023
- Due
- 31 Dec 2024
- Delivered
- June 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“full results by year-end 2024”
What we found
Evidence strength A What the grades mean
The company reported results for the first phase of the CATALYST trial in April 2025 and the second phase in June 2025, missing the year-end 2024 deadline.
-
A Corcept Therapeutics Inc. 10-Q filed 2025-07-31
“CATALYST’s results were published in Diabetes Care (Buse et al., April 2025 (first phase) and DeFronzo et al., June 2025 (second phase))” ✓ confirmed on the page
Market reaction: the shares moved +3.2% against the S&P 500 over the three sessions around the disclosure (30 Jul 2025 to 4 Aug 2025). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- CATALYST trial full results
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Corcept Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2023-CORT-002885 · Corrections policy